SISCAPA Assay Technologies
Dr. Anderson obtained his BA in Physics from Yale and a PhD in Molecular Biology from Cambridge University (England), has published 170 papers and been granted 44 US Patents. He co-founded Large Scale Biology, an early proteomics company that IPO'd in 2000, has served on the board of directors of Dade Behring (a global diagnostics company) and Luna Innovations (fiber-optic test and measurement). He received the 1983 Pittsburgh Analytical Chemistry Award; the 2008 Award for Outstanding Contributions to Animal Clinical Chemistry (AACC Division of Animal Clinical Chemistry); and the 2009 HUPO Distinguished Achievement Award in Proteomic Science.
This person is not in any offices
SISCAPA Assay Technologies
SISCAPA technology is the smart shortcut to the sensitive quantitation of protein biomarkers and targets. SISCAPA assays combine the precision of MRM mass spectrometry with the power of affinity enrichment to deliver a superior alternative to conventional immunoassays for protein quantitation.